COMMUNIQUÉS West-GlobeNewswire

Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer
07/10/2024
QIAGEN’s leading tuberculosis blood test QuantiFERON®-TB Gold Plus remains crucial for detection of latent tuberculosis infection, aiding in breaking the cycle of disease transmission // Over 35 top tuberculosis experts [...]
Inari Medical to Announce Third Quarter 2024 Financial Results
07/10/2024
IRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]
Range Impact Announces Uplisting to the OTCQB Venture Market
07/10/2024
CLEVELAND, OHIO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public company dedicated to improving the health and wellness of people and the planet through a [...]
TerrAscend to Host Third Quarter 2024 Earnings Conference Call
07/10/2024
TORONTO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF) , a leading North American cannabis company, today announced that it will host a scheduled [...]
Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates
07/10/2024
VIP943 demonstrates promising safety and tolerability and achieves two complete responses to date in Phase 1 dose-escalation study, reinforcing the program’s potential and validating the VersAptx™ Platform technology [...]
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
07/10/2024
FOSTER CITY, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer
07/10/2024
A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of Aquablation Therapy in Men with Grade Group 1 to 3 Localized Prostate Cancer Represents Potential Paradigm Shift in How Urologists Might [...]
Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway
07/10/2024
Company advancing BDTX-1535 in EGFRm NSCLC towards key inflection points in Q1 2025 Will deprioritize BDTX-4933 and seek potential partners Anticipated cost savings expected to extend cash runway into Q2 2026 CAMBRIDGE [...]
Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation
07/10/2024
Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation PARIS, France, October 7, 2024, 10:00 p.m. CEST – Abivax SA ( [...]
Simtra BioPharma Solutions Expands Capabilities with $14M Investment in ADC Conjugation and Purification Clinical Suite
07/10/2024
Enhancing End-to-End Service Offering for Accelerated Development and Manufacturing of Antibody-Drug Conjugates (ADCs) as part of the scaling of its Development Services Business PARSIPPANY, N.J., Oct. 07, 2024 (GLOBE [...]
MEDIROM Rehab Solutions Inc. Acquires Rehabilitation Centers from Y’s, Inc.
07/10/2024
TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”) is pleased to announce that it is capitalizing on its extensive experience operating wellness [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
07/10/2024
Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 7 octobre 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
07/10/2024
Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 7 octobre 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
07/10/2024
Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 7 octobre 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
EssilorLuxottica: Third-Quarter 2024 Revenue Conference Call Invitation
07/10/2024
Third-Quarter 2024 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our Third-Quarter 2024 Revenue [...]
EssilorLuxottica: Third-Quarter 2024 Revenue Conference Call Invitation
07/10/2024
Third-Quarter 2024 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our Third-Quarter 2024 Revenue [...]
Safe Group et SpineUp au NASS 2024 : des synergies pour accélérer le déploiement des solutions
07/10/2024
Safe Group et SpineUp au NASS 2024 : des synergies pour accélérer le déploiement des solutions Fleurieux-sur-l’Arbresle - France - le 7 octobre 2024 à 18h . Safe SA (FR001400F1V2 – ALSAF), spécialiste dans la conception [...]
Breakthrough in Brain–Computer Interface Technology: A New Era of Neural Decoding at the Society for Neuroscience Annual Meeting, Neuroscience 2024
07/10/2024
Precision Neuroscience’s Cortical Surface Array unlocks an unprecedented view of neural patterns, poised to revolutionize neural decoding NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Researchers shared groundbreaking [...]
CytoDyn Announces Abstract that Highlights Leronlimab’s Potential in Mediating ART-Free Viral Control in Infant Rhesus Macaques
07/10/2024
Abstract to be presented at the 5 th annual HIV Research for Prevention Conference Study results highlight potential for treatment VANCOUVER, Washington, Oct. 07, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (" [...]

Pages